Agilent gets FDA approval for expanded cancer testing platform

June 2, 2026 4:15 PM

Agilent Technologies Inc. (NYSE: A) received U.S. Food and Drug Administration approval to expand use of its PD-L1 IHC 22C3 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found